Table 3.
Annual prevalence of PrEP use per 100,000 population by state, region, and the corresponding Estimated Annual Percent Change (EAPC), Unites States 2012-17
| Prevalence of active PrEP prescriptions*, year | EAPC | |||||||
|---|---|---|---|---|---|---|---|---|
| Region | State | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2012-2017 |
| Midwest | Illinois | 3.1 | 4.8 | 14.6 | 32.0 | 41.1 | 50.4 | +59% |
| Indiana | 1.9 | 2.8 | 4.7 | 12.3 | 17.3 | 22.4 | +62% | |
| Iowa | 2.3 | 3.1 | 5.7 | 12.9 | 17.7 | 26.0 | +62% | |
| Kansas | 2.3 | 1.9 | 5.3 | 11.2 | 13.4 | 16.4 | +49% | |
| Michigan | 1.7 | 2.7 | 5.9 | 13.0 | 16.1 | 21.6 | +58% | |
| Minnesota | 2.4 | 4.0 | 9.0 | 19.1 | 28.1 | 34.8 | +62% | |
| Missouri | 1.5 | 3.1 | 6.4 | 15.9 | 21.1 | 26.0 | +61% | |
| Nebraska | 1.8 | 2.6 | 4.1 | 9.5 | 10.1 | 15.0 | +50% | |
| North Dakota | 0.5 | 1.8 | 3.4 | 5.2 | 8.5 | 13.2 | +66% | |
| Ohio | 2.0 | 2.9 | 6.9 | 16.9 | 25.4 | 34.3 | +70% | |
| South Dakota | 0.9 | 2.0 | 3.3 | 9.2 | 9.7 | 10.7 | +48% | |
| Wisconsin | 1.7 | 2.2 | 4.7 | 11.2 | 15.1 | 18.8 | +59% | |
| Northeast | Connecticut | 5.9 | 6.7 | 15.7 | 30.0 | 31.1 | 39.7 | +43% |
| Maine | 2.5 | 3.7 | 5.7 | 12.0 | 14.6 | 19.5 | +49% | |
| Massachusetts | 14.0 | 18.0 | 31.3 | 59.1 | 58.9 | 65.1 | +34% | |
| New Hampshire | 3.4 | 5.3 | 9.5 | 16.5 | 19.6 | 21.6 | +40% | |
| New Jersey | 4.5 | 5.6 | 11.2 | 22.3 | 26.1 | 35.3 | +49% | |
| New York | 6.0 | 12.0 | 25.4 | 54.3 | 75.8 | 102.8 | +63% | |
| Pennsylvania | 3.6 | 4.7 | 8.7 | 18.9 | 25.2 | 35.0 | +57% | |
| Rhode Island | 7.6 | 11.2 | 22.5 | 43.7 | 47.9 | 59.2 | +45% | |
| Vermont | 1.5 | 1.3 | 6.5 | 11.6 | 11.3 | 15.5 | +46% | |
| South | Alabama | 1.6 | 2.7 | 4.3 | 10.8 | 15.5 | 22.0 | +66% |
| Arkansas | 1.7 | 1.6 | 4.3 | 8.9 | 11.7 | 15.8 | +57% | |
| Delaware | 6.0 | 5.8 | 11.7 | 21.0 | 30.4 | 37.9 | +49% | |
| District of Columbia | 14.9 | 20.0 | 74.6 | 176.4 | 267.7 | 318.5 | +67% | |
| Florida | 5.1 | 5.7 | 10.8 | 23.5 | 31.9 | 43.0 | +56% | |
| Georgia | 3.4 | 3.8 | 9.5 | 19.6 | 25.4 | 31.2 | +53% | |
| Kentucky | 1.3 | 1.9 | 4.4 | 9.6 | 12.0 | 16.0 | +58% | |
| Louisiana | 2.8 | 3.7 | 6.7 | 14.6 | 18.3 | 27.8 | +58% | |
| Maryland | 4.0 | 5.0 | 10.6 | 23.2 | 29.7 | 39.9 | +57% | |
| Mississippi | 1.5 | 1.6 | 4.5 | 9.2 | 11.7 | 14.7 | +54% | |
| North Carolina | 2.6 | 3.1 | 6.5 | 14.5 | 17.3 | 21.1 | +50% | |
| Oklahoma | 1.2 | 1.4 | 3.5 | 9.4 | 12.2 | 14.9 | +60% | |
| South Carolina | 1.8 | 2.0 | 4.9 | 9.4 | 11.4 | 14.1 | +49% | |
| Tennessee | 1.9 | 2.1 | 5.3 | 12.5 | 16.8 | 24.0 | +65% | |
| Texas | 2.5 | 3.3 | 8.6 | 18.1 | 21.3 | 28.5 | +54% | |
| Virginia | 3.7 | 4.1 | 8.2 | 16.2 | 19.3 | 24.7 | +47% | |
| West Virginia | 1.2 | 1.9 | 4.3 | 8.2 | 9.8 | 14.6 | +56% | |
| West | Alaska | 1.3 | 2.0 | 3.7 | 9.5 | 10.6 | 14.5 | +55% |
| Arizona | 3.2 | 3.8 | 7.0 | 13.0 | 17.4 | 27.1 | +56% | |
| California | 3.4 | 5.4 | 12.0 | 24.8 | 31.8 | 39.1 | +54% | |
| Colorado | 2.3 | 4.1 | 8.6 | 18.4 | 22.6 | 30.6 | +56% | |
| Hawaii | 2.2 | 2.2 | 5.4 | 13.0 | 17.6 | 20.1 | +56% | |
| Idaho | 0.8 | 1.7 | 3.5 | 7.3 | 10.9 | 13.4 | +62% | |
| Montana | 1.1 | 2.2 | 2.3 | 7.0 | 9.2 | 10.8 | +53% | |
| Nevada | 1.8 | 3.4 | 6.3 | 15.2 | 22.1 | 31.2 | +68% | |
| New Mexico | 2.2 | 2.9 | 5.3 | 11.0 | 14.2 | 21.3 | +57% | |
| Oregon | 2.5 | 3.8 | 9.4 | 19.3 | 27.2 | 37.2 | +63% | |
| Utah | 1.3 | 2.6 | 6.9 | 17.5 | 22.7 | 29.1 | +63% | |
| Washington | 3.3 | 4.7 | 14.4 | 32.5 | 44.1 | 56.5 | +63% | |
| Wyoming | 0.4 | 1.5 | 1.7 | 3.5 | 5.4 | 6.0 | +52% | |
| Puerto Rico | 0.5 | 0.5 | 0.8 | 2.2 | 1.9 | 1.4 | +29% | |
*
Yearly prevalence of active PrEP prescriptions per 100,000 population aged 13 and above